AFT Pharmaceuticals (NZX: AFT; ASX: AFP), New Zealand’s largest domestic pharmaceuticals company, today advises that Stuart Houliston will commence as the Chief Financial Officer on 15 June 2026.
As advised in March, Malcolm Tubby will retire from the role on 29 May 2026 and Simon Bosley will take over the role in the interim period.
AFT Chair David Flacks said: “We are delighted Stuart has agreed to join the company. Stuart brings financial expertise from both public markets and the accounting profession which will strongly support the future strategy and growth of the business.”
Stuart joins the company from Sanford, New Zealand’s largest integrated fishing and aquaculture company with circa $500 million revenue. Prior to that Stuart was an audit Director at KPMG with a broad range of commercial businesses. He is a chartered accountant and a Master of Science from Oxford University.
AFT Pharmaceuticals Co-Founder and Managing Director Dr Hartley Atkinson said: “AFT is looking forward to working with Stuart to further our growth as we action many initiatives both locally and around the globe.”
Stuart Houliston said: “I am delighted to be joining AFT. The company has a proven record of growth in its 29 years and its ability to develop medicines with a global application. The growth continues to gain momentum, and I am looking forward to being part of the team on this journey.”
Released for, and on behalf of, AFT Pharmaceuticals Limited by Malcolm Tubby, Chief Financial Officer.
